[279 Pages Report] The overall research antibodies market is expected to grow from USD 9.33 billion in 2017 to USD 12.60 billion by 2022, at a CAGR of 6.2% from 2017 to 2022. Research-use antibodies and reagents are integral components in the field of life science research for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing. The growth in Proteomics and Genomics research, rising demand for high-quality antibodies for research reproducibility, and the increasing R&D activities and expenditure in the life sciences industry are aiding the growth of the market. The growing demand for protein therapeutics and personalized medicine, coupled with the development of newly engineered proteins, is expected to open growth avenues for research markets in terms of the uptake of antibodies and reagents. The base year considered for the study is 2017, and the forecast has been provided for the period between 2018 and 2023.

MnM helped a global leader in research antibodies market, to tap into a $ 2 billion market with a projected revenue of $75 Mn in 5 years from this project. Client�s Problem Statement The client, a global leader in reagents and instrument market, wanted to assess the reagents/consumables market for flow cytometry and other in-vitro imaging techniques (ELISA, WB, FISH & IHC). The client was interested to know the market share of leading players in the reagent and consumables market for the focused technologies. Further, the client also wanted to know, market by end user, technology, go to market strategy. The other objectives included market dynamics, market sizing and competitive landscape. MnM Approach Authentic secondary sources (government websites, associations and groups, annual reports of companies, SEC filings, corporate presentations) were screened along with MnM repository to gain insights, both quantitative and qualitative, into the reagents and consumables market for focused technologies. Market size estimation was performed by both top-down and bottom-up approaches. At each level, data was validated by primary interviews including demand side (Application specialists, Laboratory Head, Research Scholars) and supply side (Top level executives, General Managers, Senior Managers, Product/Sales /Marketing/Business) and other neutral opinions of independent consultants and KOLs and the estimates were finally validated by MarketsandMarkets domain experts Revenue Impact (RI) MnM helped a global leader in research antibodies market, to tap into a $ 2 billion market with a projected revenue of $75 Mn in 5 years from this project. Consult our Analyst now

Market Dynamics

Drivers

Increasing R&D activity and funding for R&D

Growing industry-acedemia collaborations

Opportunities

High growth opportunities in emerging markets

Increasing demand for personalized medicine and protein therpaeutics

Growth in stem cell and neurobiology research

Increasing focus on biomarker discovery

Challenges

Quality concerns over research antibodies

Cost- and time-intensive antibody development processes

Pricing pressure faced by prominent market players

Increasing stem cell and neurobiology research provide significant growth opportunities<

Antibodies are a powerful tool for characterizing, isolating, and analyzing stem cells and their derivatives. Through the use of flow cytometry, antibodies help researchers obtain population-based statistics and multi-parametric data on differentiating stem cell cultures, and it also allows them to isolate stem cells by using multiple fluorescent-labeled antibodies. The large stem cell product pipelines of several major companies and applications of stem cells in the treatment of various diseases are driving stem cell research activities globally. Also, Neurobiology research relies on antibodies to identify and elucidate reactions on a cellular, molecular, or biochemical level, thus enabling the better understanding of neuroscience processes and neuronal diseases. With the increasing incidence of various neurological disorders, a number of research activities are being undertaken in this field. This will offer significant growth opportunities to market players focusing on developing stem cell and neuroscience research antibodies.

The following are the major objectives of the study.

To define, describe, segment, and forecast the global research antibodies and reagents market, on the basis of product, technology, application, end-user, and region

To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)

To analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market

To analyze the market opportunities for stakeholders and provide details of the competitive landscape for market players

To forecast the size of the global market, in five main regions (along with countries) North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle-East and Africa (MEA)

To profile key players in the global market and comprehensively analyze their core competencies2 and market shares

To track and analyze competitive developments, such as new product/technology developments partnerships; mergers and acquisitions; expansions; and R&D activities of the leading players in the research antibodies and reagents market

During this research study, major players operating in the market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global research antibodies market (including reagents) are Thermo Fisher Scientific, Inc. (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), Cell Signaling Technology, Inc. (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), GenScript (US), PerkinElmer, Inc. (US), Lonza (Switzerland), and BioLegend, Inc. (US).

Major Market Developments

In January 2017, Merck expanded its end-to-end bio-development centers in North America, China, and Europe to meet increasing customer demand and also to increase its manufacturing capabilities.

In March 2016, Thermo Fisher Scientific (US) acquired Affymetrix, Inc. (US) expanding the company�s research antibody portfolio, and strengthening its leadership in the biosciences business. It also helped Thermo Fisher add new genetic analysis capabilities in the clinical and applied markets.

In April 2016, Abcam launched a suite of immunoassay, products based on recombinant monoclonal antibody pairs used in ELISA to study secreted biomarkers by life science researchers

Target Audience:

Pharmaceutical and Biotechnology Companies

Life Sciences Companies

Academic Research Institutes

Government Institutes

Private Research Firms

Contract Research Organizations (CROs)

Venture Capitalists and Investors

Report Scope

Global Research Antibodies Market, by Product

Antibodies Antibodies Market, by Type Primary Antibodies Secondary Antibodies Antibodies Market, by Source Mouse Rabbit Others Antibodies Market, by Research Area Oncology Infectious Diseases Neurobiology Stem Cell Immunology Others

Reagents Stains & Dyes Media & Sera Fixatives Buffers Probes Solvents Enzymes Others



Global Research Antibodies Market, by Technology

Western Blotting

Flow Cytometry

Enzyme-linked Immunosorbent Assay

Immunohistochemistry

Immunofluorescence

Immunoprecipitation

Others

Research Antibodies Market, by Application

Proteomics

Drug Development

Genomics

Global Research Antibodies Market, by End User

Pharmaceutical & Biotechnological Companies

Academic & Research Institutes

Contract Research Organizations

Global Research Antibodies Market, by Region

North America US Canada

Europe Germany UK France Italy Spain Rest of Europe

Asia-Pacific China Japan India Rest of Asia-Pacific

Latin America

Middle East & Africa

Critical questions which the report answers

What are new technology areas which the research antibody companies are exploring?

Which are the key players in the market and how intense is the competition?

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports as per the client�s specific requirements. The available customization options are as follows:

Geographic Analysis

Further breakdown of the Rest of Asia-Pacific�s research antibodies market into South Korea, Australia, New Zealand, and other Asian countries

Further breakdown of the Latin American research antibodies market into Brazil, Argentina, and other Latin American countries.

Company Information

Detailed analysis and profiling of additional research antibodies market players (Up to 5)

The overall research antibodies market is expected to grow from USD 9.33 billion in 2017 to USD 12.60 billion by 2022 at a CAGR of 6.2%. The growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and the increasing R&D activities and expenditure in the life sciences industry are the key factors driving the growth of the research antibodies market.

Research-use antibodies and reagents are integral components in the field of life science research for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing. They are extensively used for the characterization of proteins and nucleic acids for proteomic and genomic research. Due to their high specificity and selectivity, antibodies have great potential as research tools in a wide range of biochemical and medical research applications. Research-use antibodies are majorly used for protein-target identification, regulatory characterization, and discovery, and continue to be the gold-standard choice for protein identification, detection, modification, and alteration, as well as for monitoring expression and cellular regulation. Over the years, with the increasing research being held in various fields the market for research antibodies and reagents has witnessed significant growth.

The research antibodies and reagents market has been segmented, on the basis of product, into reagents and antibodies. The market for antibodies is expected to grow at the highest CAGR between 2018 and 2023. On the other hand, among all the reagents, stains and dyes are being widely used. Their high adoption for enhanced visualization in cell biology, molecular, and histological studies is increasing with the growth in the life science research industry.

On the basis of technology, western blotting segment held the largest share of the global market due to the high adoption of this technique in proteomic and genomic research, as it can accurately show the presence of a specific protein, both by size and through binding of an antibody. Also, the results achieved are easy to interpret, unique, and unambiguous, making it well-suited for evaluating levels of protein expression in cells, monitoring fractions during protein purification, and for comparing expression of a target protein from various tissues.

The pharmaceutical & biotechnology companies hold a significant share of the market by end user. This can be attributed to the wide use of research antibodies in the drug development process, for the identification and quantification of biomarkers, and in various analytical procedures.

The research antibodies and reagents market in APAC is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is primarily due to growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics in the region.

Proteomics research in drive the growth of research antibodies and reagents market

Proteomics

Proteomics refers to the experimental analysis of proteins, along with its purification and Mass Spectrometry studies. These studies require the generation of specific and high-affinity antibodies against large numbers of proteins to study their expression and function. The availability of thoroughly validated antibodies helps in understanding the protein expression, localization, function, and fundamental processes of living organisms. Antibody-based proteomics is imperative for biomarker discovery and validation, facilitating the high-throughput evaluation of candidate markers. These markers are used in the early detection of diseases, such as cancer, Alzheimer�s, and immunological disorders, while providing diagnostic and prognostic information.

Drug Development

Successful drug discovery is dependent on the correct identification of a target implicated in disease, followed by the successful selection, optimization, and development of a candidate drug. Due to their specific binding characteristics with regard to specificity, affinity, and avidity, along with their amenability to protein engineering, antibodies have become a key tool in drug discovery, enabling the quantification, localization, and modulation of proteins of interest. Antibodies are utilized throughout the drug discovery process�from target identification to patient stratification. They are used to investigate target distribution, subcellular localization, function, and more importantly how these factors play a role in the disease pathway.

Genomics

Research in the genomics field involves the use of antibodies to understand the aspects of gene transcription, translation, protein-protein interactions, and 3D structure of every protein encoded by a given genome; study of epigenetic modifications; and structure determination using a combination of experimental and modeling approaches. Antibodies thus play a pivotal role in gene expression and regulation studies.

Critical questions the report answers:

Where will all these developments take the industry in the mid to long term?

What are the upcoming industry technologies in the research antibodies market?

Variations in antibody production techniques have resulted in a lack of reproducibility of results. Batch variations are subject to variations from animal to animal and purification to purification, and there are no standards for their validation nor agreed-upon definitions of reproducibility across all antibody offerings. These batch-to-batch variations hold true for monoclonal antibodies, but to a much larger extent, this is the case for polyclonal antibodies. The lot-to-lot variability of these antibodies significantly affects the results of basic and fundamental research and clinical screening tests. Thus, research-use antibodies need proper validation before being used in scientific research. With the growing focus on antibody quality, research reproducibility, and technological advancements, the vendors need to ultimately offer higher quality products in the market.

Key players in the Research Antibodies Market include Thermo Fisher Scientific Inc. (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), Cell Signaling Technology, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Agilent Technologies, Inc. (US), PerkinElmer, Inc. (US), Lonza (Switzerland), GenScript (China), and BioLegend, Inc. (US).. These players are increasingly undertaking product launches to develop and introduce new technologies, expansions, mergers and acquisitions, and agreements to alleviate their market position.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst